Part 2: Amniotic Membrane Speeds Healing


In part one of a two-part series, Josh Johnston, OD discussed the paradigm shift in treating patients with dry eye. Here, he speaks to Primary Care Optometry News (PCON) about cryopreserved amniotic membrane and how it speeds healing.

In his last blog, Josh Johnston, OD, Georgia Eye Partners, spoke about the “Paradigm Shift in Treating Patients with Dry Eye” and how the introduction of new therapies allows doctors to provide better outcomes to patients and improve clinical outcomes. One of the therapies he spoke of is PROKERA with cryopreserved amniotic membrane, and its many benefits particularly for those patients with corneal involved dry eye.

Part 1: The Paradigm Shift in Treating Dry Eye


In part one of a two–part series, Josh Johnston, OD discusses the paradigm shift in treating patients with dry eye.

Treating dry eye disease (DED) has truly evolved over the past years, and even more so recently with new diagnostics, therapies and FDA-approved drugs. We all know DED is progressive and can be hard to treat, which is actually one of the reasons I like it so much. It’s an exciting time for those of us treating DED. The paradigm shift has changed and there are new, novel products and therapies at our disposal that allow us to provide better options to patients and improve clinical outcomes.

Bio-Tissue’s Dry Eye Center of Excellence Program


Our company’s groundbreaking scientific research in the study of regenerative medicine has led to the development of innovative products that are used worldwide by eye care professionals to treat ocular surface disease (OSD), including dry eye. In order to help you leverage our products, elevate the level of care you provide to your patients, improve clinical outcomes, and grow your practice, we developed the Dry Eye Center of Excellence Program (DECE).

Part 2: The Business Impact of Offering Cliradex in Your Practice


In part two of her series, Patti Barkey, CEO, Bowden Eye & Associates, in Jacksonville, Fla., discusses how Cliradex has assisted in practice efficiency, clinical outcomes and how it has improved business and their bottom line.

Part 1: The Business Impact of Offering Cliradex in Your Practice


In part one of a two-part series, Patti Barkey, CEO, Bowden Eye & Associates, in Jacksonville, Fla., discusses why they decided to implement Cliradex in their practice, how it fits into their “Dry Eye Disease" toolbox, and how it is used.

Research to be Presented at ASCRS that Further Demonstrates Effectiveness of Cryopreserved Amniotic Membrane for Ocular Surface Healing


This week we issued a press release announcing the presentation of key research at this week’s American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, May 5-9. This research further demonstrates the clinical effectiveness of PROKERA, our biologic corneal bandage with cryopreserved amniotic membrane tissue.

Cosmetics and Demodex


In part two of her series, Sarah Darbandi, MD discusses the role of cosmetics in Demodex and the importance of daily ocular hygiene.

Q:             Is there a correlation between cosmetics and Demodex?

A:              Yes. Typically what I see under the microscope is layers of dead skin, collarettes, with mascara stuck to it and eye shadow particles entrapped in the sleeves of debris on the lashes. Since some ingredients in makeup are toxic for dry eye patients who are already very sensitive, this is just one more insult to their eyelids. They typically have red, irritated eyes, and with makeup they are adding waxes and parabens that block the glands and add more inflammation.

Cosmetics and Blepharitis – A Two Part Series


In part one of a two-part series, Sarah Darbandi, MD discusses the effects of cosmetics on the eyes, particularly for patients with dry eye and blepharitis.

Q:             How are cosmetics harmful to the eyes, particularly for patients with dry eye or blepharitis?

There are many things we apply around our eyes and on our eyelids, which is the thinnest skin on our body, including cleanser, moisturizer, under eye cream, concealer, eye shadow, mascara, eyeliners and more. Many of these products contain wax (synthetic, paraffin or beeswax) as well as potentially toxic chemicals such as carcinogens and parabens. Although parabens prevent the growth of bacteria in makeup, they can be absorbed through the skin and transmitted into the bloodstream. Parabens can also make dry eye worse as they prohibit the oil glands that line the eyelid from secreting enough oil.

Five Key Facts About Bio-Tissue


As we begin the new year, we wanted to share some key facts about Bio-Tissue. As one of five companies to be profiled as “One to Watch” in the year-end issue of Advanced Ocular Care, we continue our focus to provide groundbreaking regenerative solutions to eye care practitioners and patients around the world. Here are five key facts:

A Year of New Developments


Our company implemented many key initiatives this year in our continued effort to bring innovative regenerative solutions to eye care professionals around the world. As 2016 nears the end, following are just a few of these key efforts: